Literature DB >> 28386018

PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.

Smrita Sinha1,2,3, Ya-Yuan Fu3, Adrien Grimont1, Maren Ketcham4, Kelly Lafaro1, Joseph A Saglimbeni1, Gokce Askan1,5, Jennifer M Bailey6, Jerry P Melchor1, Yi Zhong1, Min Geol Joo7, Olivera Grbovic-Huezo1, In-Hong Yang7, Olca Basturk5, Lindsey Baker8, Young Park8, Robert C Kurtz2, David Tuveson8, Steven D Leach9, Pankaj J Pasricha10.   

Abstract

Nerves are a notable feature of the tumor microenvironment in some epithelial tumors, but their role in the malignant progression of pancreatic ductal adenocarcinoma (PDAC) is uncertain. Here, we identify dense innervation in the microenvironment of precancerous pancreatic lesions, known as pancreatic intraepithelial neoplasms (PanIN), and describe a unique subpopulation of neuroendocrine PanIN cells that express the neuropeptide substance P (SP) receptor neurokinin 1-R (NK1-R). Using organoid culture, we demonstrated that sensory neurons promoted the proliferation of PanIN organoids via SP-NK1-R signaling and STAT3 activation. Nerve-responsive neuroendocrine cells exerted trophic influences and potentiated global PanIN organoid growth. Sensory denervation of a genetically engineered mouse model of PDAC led to loss of STAT3 activation, a decrease in the neoplastic neuroendocrine cell population, and impaired PanIN progression to tumor. Overall, our data provide evidence that nerves of the PanIN microenvironment promote oncogenesis, likely via direct signaling to neoplastic neuroendocrine cells capable of trophic influences. These findings identify neuroepithelial cross-talk as a potential novel target in PDAC treatment. Cancer Res; 77(8); 1868-79. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28386018      PMCID: PMC5471615          DOI: 10.1158/0008-5472.CAN-16-0899-T

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Enteroendocrine cells support intestinal stem-cell-mediated homeostasis in Drosophila.

Authors:  Alla Amcheslavsky; Wei Song; Qi Li; Yingchao Nie; Ivan Bragatto; Dominique Ferrandon; Norbert Perrimon; Y Tony Ip
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

2.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

3.  Endocrine-paracrine cells in pancreatic exocrine carcinomas.

Authors:  V Eusebi; C Capella; A Bondi; F Sessa; P Vezzadini; A M Mancini
Journal:  Histopathology       Date:  1981-11       Impact factor: 5.087

4.  Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.

Authors:  Han Bai; Haonan Li; Wanying Zhang; Kristina A Matkowskyj; Jie Liao; Sanjay K Srivastava; Guang-Yu Yang
Journal:  Carcinogenesis       Date:  2011-08-22       Impact factor: 4.944

5.  Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.

Authors:  Helmut Friess; Zhaowen Zhu; Veronique Liard; Xin Shi; Shailesh V Shrikhande; Li Wang; Klaus Lieb; Murray Korc; Carla Palma; Arthur Zimmermann; Jean Claude Reubi; Markus W Büchler
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

6.  Rapid degradation of [3H]-substance p in guinea-pig ileum and rat vas deferens in vitro.

Authors:  S P Watson
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

7.  Distribution and neurochemical identification of pancreatic afferents in the mouse.

Authors:  Kenneth E Fasanella; Julie A Christianson; R Savanh Chanthaphavong; Brian M Davis
Journal:  J Comp Neurol       Date:  2008-07-01       Impact factor: 3.215

8.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.

Authors:  Laszlo Karai; Dorothy C Brown; Andrew J Mannes; Stephen T Connelly; Jacob Brown; Michael Gandal; Ofer M Wellisch; John K Neubert; Zoltan Olah; Michael J Iadarola
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.

Authors:  Walter M Klein; Ralph H Hruban; Andres J P Klein-Szanto; Robb E Wilentz
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

10.  Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

Authors:  Susana Garcia-Recio; Gemma Fuster; Patricia Fernandez-Nogueira; Eva M Pastor-Arroyo; So Yeon Park; Cristina Mayordomo; Elisabet Ametller; Mario Mancino; Xavier Gonzalez-Farre; Hege G Russnes; Pablo Engel; Domiziana Costamagna; Pedro L Fernandez; Pedro Gascón; Vanessa Almendro
Journal:  Cancer Res       Date:  2013-09-12       Impact factor: 12.701

View more
  32 in total

1.  Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Jami L Saloman; Aatur D Singhi; Douglas J Hartman; Daniel P Normolle; Kathryn M Albers; Brian M Davis
Journal:  Pancreas       Date:  2018-08       Impact factor: 3.327

Review 2.  Exosomal Induction of Tumor Innervation.

Authors:  Paola D Vermeer
Journal:  Cancer Res       Date:  2019-05-14       Impact factor: 12.701

Review 3.  Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.

Authors:  Abigail C Cornwell; Michael E Feigin
Journal:  Trends Pharmacol Sci       Date:  2020-10-22       Impact factor: 14.819

Review 4.  Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Authors:  Peter Storz; Howard C Crawford
Journal:  Gastroenterology       Date:  2020-03-19       Impact factor: 22.682

Review 5.  Sympathetic and parasympathetic innervation in cancer: therapeutic implications.

Authors:  Atsunori Kamiya; Takeshi Hiyama; Atsushi Fujimura; Soichiro Yoshikawa
Journal:  Clin Auton Res       Date:  2020-09-14       Impact factor: 4.435

Review 6.  Nerves in cancer.

Authors:  Ali H Zahalka; Paul S Frenette
Journal:  Nat Rev Cancer       Date:  2020-01-23       Impact factor: 60.716

7.  β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Authors:  Bernhard W Renz; Ryota Takahashi; Takayuki Tanaka; Marina Macchini; Yoku Hayakawa; Zahra Dantes; H Carlo Maurer; Xiaowei Chen; Zhengyu Jiang; C Benedikt Westphalen; Matthias Ilmer; Giovanni Valenti; Sarajo K Mohanta; Andreas J R Habenicht; Moritz Middelhoff; Timothy Chu; Karan Nagar; Yagnesh Tailor; Riccardo Casadei; Mariacristina Di Marco; Axel Kleespies; Richard A Friedman; Helen Remotti; Maximilian Reichert; Daniel L Worthley; Jens Neumann; Jens Werner; Alina C Iuga; Kenneth P Olive; Timothy C Wang
Journal:  Cancer Cell       Date:  2017-12-14       Impact factor: 31.743

8.  Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer.

Authors:  Robert S Banh; Douglas E Biancur; Keisuke Yamamoto; Albert S W Sohn; Beth Walters; Miljan Kuljanin; Ajami Gikandi; Huamin Wang; Joseph D Mancias; Robert J Schneider; Michael E Pacold; Alec C Kimmelman
Journal:  Cell       Date:  2020-11-02       Impact factor: 41.582

Review 9.  Harnessing metabolic dependencies in pancreatic cancers.

Authors:  Joel Encarnación-Rosado; Alec C Kimmelman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-19       Impact factor: 46.802

Review 10.  Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer.

Authors:  Alyssa Schledwitz; Guofeng Xie; Jean-Pierre Raufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.